In today’s Pharma Pulse, Johnson & Johnson commits over $1 billion to a new biomanufacturing site in Pennsylvania, while Hims ...
Patients want pills. We see this in the GLP-1 space. Everything should actually be flowing money towards pills, because payers are also quicker to reward pills. Yet the money is going exactly in the ...
The $300 Billion Pharma Patent Cliff: Why M&A Is Exploding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results